Pusoon Chun Selected Research

(Z)- 5- (2,4- dihydroxybenzylidene)thiazolidine- 2,4- dione

10/2013	Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor.
8/2013	The inhibitory effect of a synthetic compound, (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione (MHY498), on nitric oxide-induced melanogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pusoon Chun Research Topics

Disease

22	Melanoma (Melanoma, Malignant) 07/2022 - 07/2012
9	Hyperpigmentation 12/2023 - 10/2013
8	Inflammation (Inflammations) 05/2021 - 01/2013
6	Neoplasms (Cancer) 10/2018 - 08/2010
5	Pigmentation Disorders (Ito Syndrome) 01/2019 - 10/2013
5	Insulin Resistance 01/2018 - 01/2013
4	Body Weight (Weight, Body) 05/2021 - 01/2013
3	Fibrosis (Cirrhosis) 12/2020 - 01/2015
2	Obesity 01/2018 - 01/2017
2	Fatty Liver 01/2018 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2013
2	Melanosis (Freckles) 01/2018 - 10/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 05/2015 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 03/2014 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2014 - 10/2011
1	Atrial Fibrillation 12/2020
1	Heart Diseases (Heart Disease) 12/2020
1	Cardiomegaly (Heart Hypertrophy) 12/2020
1	Heart Failure 12/2020
1	Hypertension (High Blood Pressure) 12/2020
1	Myocardial Infarction 12/2020
1	Atrial Remodeling 12/2020
1	Adenocarcinoma 10/2018
1	Kidney Diseases (Kidney Disease) 02/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2018
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 02/2018
1	Lupus Nephritis 02/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Hyperinsulinism (Hyperinsulinemia) 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Weight Gain 01/2017
1	Lymphoma (Lymphomas) 06/2015
1	Hematologic Neoplasms (Hematological Malignancy) 06/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Osteoporosis 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Skin Diseases (Skin Disease) 10/2013
1	Experimental Melanoma 10/2013

Drug/Important Bio-Agent (IBA)

26	Monophenol Monooxygenase (Tyrosinase)IBA 12/2023 - 07/2012
19	Melanins (Melanin)IBA 07/2022 - 07/2012
9	Melanocyte-Stimulating Hormones (MSH)IBA 05/2021 - 07/2012
5	kojic acidIBA 07/2022 - 01/2019
4	Histone Deacetylase InhibitorsIBA 12/2020 - 08/2010
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2014
3	1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA 05/2021 - 03/2018
3	Histone Deacetylases (Histone Deacetylase)IBA 12/2020 - 08/2010
3	Insulin (Novolin)FDA Link 01/2018 - 01/2013
2	AntioxidantsIBA 01/2023 - 10/2017
2	Therapeutic UsesIBA 12/2020 - 02/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2013
2	LipidsIBA 01/2018 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 07/2017
2	Sirtuin 1IBA 01/2018 - 01/2015
2	NAD (NADH)IBA 01/2018 - 01/2015
2	AcidsIBA 01/2018 - 01/2013
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2013
2	NF-kappa B (NF-kB)IBA 10/2017 - 01/2014
2	Vorinostat FDA Link 06/2015 - 08/2010
2	SirtuinsIBA 05/2015 - 01/2015
2	N1- hydroxy- N8- (4- phenoxyphenyl)octanediamideIBA 01/2014 - 08/2010
2	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2014 - 08/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 10/2011
2	(Z)- 5- (2,4- dihydroxybenzylidene)thiazolidine- 2,4- dioneIBA 10/2013 - 08/2013
1	MHY3200IBA 05/2021
1	Bleaching AgentsIBA 01/2021
1	AmidesIBA 01/2019
1	ArbutinIBA 01/2019
1	Reducing AgentsIBA 10/2018
1	Bovine Serum AlbuminIBA 10/2018
1	GoldIBA 10/2018
1	SRT1720IBA 01/2018
1	EnzymesIBA 01/2018
1	galanginIBA 01/2018
1	ResveratrolIBA 01/2018
1	barbituric acid (barbiturate)IBA 10/2017
1	propionic acid (potassium propionate)IBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	Carboxylic AcidsIBA 09/2015
1	ThiazolidinesIBA 09/2015
1	romidepsin (FK228)FDA Link 06/2015
1	Antineoplastic Agents (Antineoplastics)IBA 06/2015
1	belinostatIBA 06/2015
1	GasesIBA 01/2015
1	Skin Lightening PreparationsIBA 01/2015
1	CosmeticsIBA 01/2015
1	MHY336IBA 03/2014
1	anthraceneIBA 01/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2014
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2014
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 08/2013
1	4- (6,7- dihydro- 5H- indeno(5,6- d)thiazol- 2- yl)benzene- 1,3- diolIBA 07/2013

Therapy/Procedure

2	Chemoprevention 03/2014 - 01/2014